chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, White blood cell count increased
Clinical narrative: generalized weakness, dry cough, bilateral interstitial infiltrates
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Heart rate increased
Clinical narrative: Squeezing sensation in chest with an increased heart rate.
Age: 1.25
Sex: M
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site swelling, Pyrexia, Rash
Clinical narrative: 11/2 developed redness and swelling at the site.  11/4 developed fever.  Fever faded and developed rash.  Likely Roseola.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Extra dose administered, Insomnia, Pain, Pain in extremity
Clinical narrative: On the night of the third dose, started out taking Tylenol, but was ineffective for the amount of pain, unable to sleep. Low grade fever. Went to the doctor and received an antibiotic and they assumed it was a UTI. Seemed to help the fever and was feeling better. Experienced lots of lower limb and back pain, taking Tylenol PM for aches and pains and to help sleep. By two weeks, I began to recover and by the third week I was feeling back to normal.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Urinary tract infection
Clinical narrative: On the night of the third dose, started out taking Tylenol, but was ineffective for the amount of pain, unable to sleep. Low grade fever. Went to the doctor and received an antibiotic and they assumed it was a UTI. Seemed to help the fever and was feeling better. Experienced lots of lower limb and back pain, taking Tylenol PM for aches and pains and to help sleep. By two weeks, I began to recover and by the third week I was feeling back to normal.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: No Adverse event. On 11/03/2021 the Vaccine Refrig data logger showed a temperature excursion occurred on 10/29/2021 at 10:48 a.m. of +50.7 (F). The timeframe documented is 13 mins with n 5 min alarm notification totaling 18 min. The vaccine providers were not aware that the vaccine needed to be used within a 24 hour timeframe of the excursion prior to discussion with the health department on 11/3/2021. A clinic was scheduled for Moderna Booster doses at a High School for their employees for 11/1/2021. This clinic did occur with the Moderna Vaccine with Lot # 076C21A between the hours of 3:00-5:00 p.m. A total of 16 people received Moderna Booster shots 0.25ml.  The vaccine provider learned on 11/3/2021 in conversations with the health department that due to the excursion, the vaccine should be discarded if not used within 24 hours of the temperature excursion. With the instructional education provided via the health department, all remaining doses of Moderna with Lot# 076C21A was wasted.
Age: 54.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Magnetic resonance imaging head normal, Migraine, Pain, Photophobia, Photopsia
Clinical narrative: The evening that I got my third dose of the vaccine, I got a pounding Migraine. After the first dose, I had a mild headache. I do not get headaches or Migraines normally. I went to the Urgent Care on the third day, after and the Toradol shot, and it did help. I returned to the ER the next day and they gave me a cocktail of painkillers. It did not really help the pain. The migraine finally subsided on 10/17/2021. When I woke up that morning, I had flashing lights in my vision. I now have a variety of vision problems after a month.  I have since had a two-hour eye exam and an MRI of my Brain. All tests have been negative, except that that they want to test my vision angles, which could have been due to inflammation. I see flashes of light, and I am very sensitive to light, as well as flashing lights at the edge of my vision. It does not seem to be improving.
Age: 54.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Visual impairment
Clinical narrative: The evening that I got my third dose of the vaccine, I got a pounding Migraine. After the first dose, I had a mild headache. I do not get headaches or Migraines normally. I went to the Urgent Care on the third day, after and the Toradol shot, and it did help. I returned to the ER the next day and they gave me a cocktail of painkillers. It did not really help the pain. The migraine finally subsided on 10/17/2021. When I woke up that morning, I had flashing lights in my vision. I now have a variety of vision problems after a month.  I have since had a two-hour eye exam and an MRI of my Brain. All tests have been negative, except that that they want to test my vision angles, which could have been due to inflammation. I see flashes of light, and I am very sensitive to light, as well as flashing lights at the edge of my vision. It does not seem to be improving.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Bradycardia, COVID-19, Cough, Dyspnoea, Endotracheal intubation
Clinical narrative: pt in ED with a positive COVID test; dx'd with respiratory failure; pt c/o N/V, SOB, cough; experienced 3 episodes of hematochezia; transferred to ICU; pt became unresponsive and vomited up blood; was intubated; bradycardia and no pulse; CPR started; pt never regained pulse or respirations
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Haematemesis, Haematochezia, Intensive care, Nausea, Pulse absent
Clinical narrative: pt in ED with a positive COVID test; dx'd with respiratory failure; pt c/o N/V, SOB, cough; experienced 3 episodes of hematochezia; transferred to ICU; pt became unresponsive and vomited up blood; was intubated; bradycardia and no pulse; CPR started; pt never regained pulse or respirations
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory arrest, Respiratory failure, Resuscitation, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: pt in ED with a positive COVID test; dx'd with respiratory failure; pt c/o N/V, SOB, cough; experienced 3 episodes of hematochezia; transferred to ICU; pt became unresponsive and vomited up blood; was intubated; bradycardia and no pulse; CPR started; pt never regained pulse or respirations
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: pt in ED with a positive COVID test; dx'd with respiratory failure; pt c/o N/V, SOB, cough; experienced 3 episodes of hematochezia; transferred to ICU; pt became unresponsive and vomited up blood; was intubated; bradycardia and no pulse; CPR started; pt never regained pulse or respirations
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Rash erythematous
Clinical narrative: I received booster at 930 am and by 250pm-I broke out in a rash like sun burn on my legs, arms, face, chest and it continued until the next night-the same night as the booster -my heart was racing all night-I am a nurse and did not go to ED-I reported my s/s to the employee health nurse the next time I saw her.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Influenza like illness, Pain
Clinical narrative: Woke feeling flu like, total body pain. Lasted for 3days, after the 3rd day, I felt better I would but every other day, I will be struck with this total body pain. Pain in my elbows and in my shoulders.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Headache
Clinical narrative: Headache, balance issues, and light headed.
Age: 6.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Crying, Inappropriate schedule of product administration, Nervousness, Seizure
Clinical narrative: patient was here with both parents on 11/6/21 around 4:15pm to get both the pfizer covid and flu vaccines. pt had stated he felt a sting after getting the covid vaccine but after getting the flu vaccine, per vaccinating technician, he seemed like he was seizing. i had advised technician to lay him on his side just in case vomiting was to occur but he had come to moments later. when he came to, he immediately hung onto mom and was crying but when asked if he was nervous, he stated he was. i had instructed a technician to call for EMS and they had inspected him upon arrival. they had given them the option to either go to the hospital or go home and monitor for abnormal signs. parents had opted to go home
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Immunodeficiency, Myalgia, Pain
Clinical narrative: Only muscular ache and not able to lift my arms without causing pain in my shoulder and arms.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Condition aggravated, Face injury, Joint injury, Loss of consciousness
Clinical narrative: Severe chills, 102F fever after 12 hours;  loss of consciousness after 20 hours - resulted in chipped jaw and injured knee
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Severe chills, 102F fever after 12 hours;  loss of consciousness after 20 hours - resulted in chipped jaw and injured knee
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Palpitations
Clinical narrative: Heart palpitations started about 10 am, I wear a fitness watch and recorded by bpm at 184 would go down to 180 back up to 184 down to 127 to 135. I didn?t call 911 as I was afraid they would admit me in hospital. I got my flu shot today and the physician said to report this adverse reaction to you. I go back to doctor on Dec 3rd and will give her the printout of my heart rate.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: na
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No Adverse event. On 11/03/2021 the Vaccine Refrig data logger showed a temperature excursion occurred on 10/29/2021 at 10:48 a.m. of +50.7 (F). The timeframe documented is 13 mins with n 5 min alarm notification totaling 18 min. The vaccine providers were not aware that the vaccine needed to be used within a 24 hour timeframe of the excursion prior to discussion with the health department on 11/3/2021. A clinic was scheduled for Moderna Booster doses at a High School for their employees for 11/1/2021. This clinic did occur with the Moderna Vaccine with Lot # 076C21A between the hours of 3:00-5:00 p.m. A total of 16 people received Moderna Booster shots 0.25ml.  The vaccine provider learned on 11/3/2021 in conversations with the health department that due to the excursion, the vaccine should be discarded if not used within 24 hours of the temperature excursion. With the instructional education provided via the health department, all remaining doses of Moderna with Lot# 076C21A was wasted.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Contusion, Hypoaesthesia, Neck pain
Clinical narrative: Patient reported neck pain on left-side, numbness in left arm, left 1st, 2nd, and 3rd digit numbness. Reports unexplained bruising to left upper back and left arm. Patient stated all symptoms started on 10/20/2021, 2 days after administration of vaccine. Patient seen by her PCP on 10/26/2021, 11/1/2021 and 11/5/2021. She reported she started on amitriptyline and a muscle relaxer, which she did not have the name readily available when calling the health department.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Back pain, Condition aggravated, Contusion, Headache
Clinical narrative: Patient reported neck pain on left-side, numbness in left arm, left 1st, 2nd, and 3rd digit numbness. Reports unexplained bruising to left upper back and left arm. Patient stated all symptoms started on 10/20/2021, 2 days after administration of vaccine. Patient seen by her PCP on 10/26/2021, 11/1/2021 and 11/5/2021. She reported she started on amitriptyline and a muscle relaxer, which she did not have the name readily available when calling the health department.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Magnetic resonance imaging normal, Movement disorder, Muscle spasms, Neck pain
Clinical narrative: Patient reported neck pain on left-side, numbness in left arm, left 1st, 2nd, and 3rd digit numbness. Reports unexplained bruising to left upper back and left arm. Patient stated all symptoms started on 10/20/2021, 2 days after administration of vaccine. Patient seen by her PCP on 10/26/2021, 11/1/2021 and 11/5/2021. She reported she started on amitriptyline and a muscle relaxer, which she did not have the name readily available when calling the health department.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neurological examination normal, Peripheral swelling
Clinical narrative: Patient reported neck pain on left-side, numbness in left arm, left 1st, 2nd, and 3rd digit numbness. Reports unexplained bruising to left upper back and left arm. Patient stated all symptoms started on 10/20/2021, 2 days after administration of vaccine. Patient seen by her PCP on 10/26/2021, 11/1/2021 and 11/5/2021. She reported she started on amitriptyline and a muscle relaxer, which she did not have the name readily available when calling the health department.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Confusional state, Contusion, Grip strength decreased, Hypoaesthesia
Clinical narrative: Patient reported neck pain on left-side, numbness in left arm, left 1st, 2nd, and 3rd digit numbness. Reports unexplained bruising to left upper back and left arm. Patient stated all symptoms started on 10/20/2021, 2 days after administration of vaccine. Patient seen by her PCP on 10/26/2021, 11/1/2021 and 11/5/2021. She reported she started on amitriptyline and a muscle relaxer, which she did not have the name readily available when calling the health department.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain
Clinical narrative: Patient reported neck pain on left-side, numbness in left arm, left 1st, 2nd, and 3rd digit numbness. Reports unexplained bruising to left upper back and left arm. Patient stated all symptoms started on 10/20/2021, 2 days after administration of vaccine. Patient seen by her PCP on 10/26/2021, 11/1/2021 and 11/5/2021. She reported she started on amitriptyline and a muscle relaxer, which she did not have the name readily available when calling the health department.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Alanine aminotransferase normal, Anion gap normal, Anticoagulant therapy, Aspartate aminotransferase increased
Clinical narrative: Date of Admission: 10/21/2021 ý Date of Discharge: 10/30/2021  69 yo female h/o of past smoking, moderqte COPD/emphysema, HTN, gout, pre-DM, vit D deficiency. She was vaccinated x2 with Pfizer vaccine, admitted on 10/21/21ýwith severe sepsis with mild acute hypoxic respiratory failure from COVID-19 PNA.  ý ý Plan: 1)Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia. Symptom onset on 10/18/21COVID positive on 10/19/21.  - Patient required oxygen via nasal cannula and received Decadron 6 mg daily during hospitalization and Remdesivir 200mg IV x1, followed by 100mg IV daily until clinical improvement (last day on 10/26/21). Patient received course of PO Levofloxacin which was started on 10/22/21 for possible superimposed pneumonia. I discussed with inpatient pharmacist on 10/27/21 and plan for last dose on Thurs 10/28/21.; patient will need follow up CXR in 6 weeks Patient received DVT prophylaxis with Heparin 5,000 units SQ q12h during hospitalization.  I discussed patient with doctor of Pulmonary on 10/28/21 who recommended Prednisone taper on discharge (30 mg PO daily for 3 days, then 20 mg PO daily for 3 days, then 10 mg PO daily for 3 days, then stop). Patient was hypoxic with 02 sat decreased to 87% RA during ambulation on 10/29/21. ý It has been arranged for home 02 with instructions to use 2 liters with activity. ýPatient will have follow-up with Home Health and econsult sent for follow-up oxygen clinic. placed referral for COVID Transitions team follow-up. Isolation through 11/7/21. ý ý2) s/p AKI (Cr increased to 1.51 on 10/21/21); on Lisinopril as outpatient which was held during hospitalization. Cr improved to 0.97 on 10/30/21. It has been arranged for Home Health to draw follow-up chem 7 in 2-3 days. ý 3) HTN; On Lisinopril as outpatient which was held during hospitalization in setting of AKI. Patient continued on Amlodipine 2.5 mg PO daily.  BP's have been stable on Amlodipine and patient was instructed to hold Lisinopril on discharge and PCC has arranged for HHRN for BP check and patient to follow-up with doctor to discuss with patient if Lisinopril should be resumed ý 4) H/o COPD; stable. Continue Stiolto and Rx for Albuterol MDI PRN shortness of breath/wheezing ý ý 5)H/o prediabetes; stable. ýPrior HbAIC 6.0% from 5/20/21. ýPatient not on medications as outpatient.  ý 6) History of gout; stable. ýOn Allupurinol ý Primary Procedures:  None ý Secondary Procedures: 10/21/21 XR Chest ý ý Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Band neutrophil count decreased, Blood bilirubin normal, Blood chloride normal, Blood creatinine increased, Blood culture
Clinical narrative: Date of Admission: 10/21/2021 ý Date of Discharge: 10/30/2021  69 yo female h/o of past smoking, moderqte COPD/emphysema, HTN, gout, pre-DM, vit D deficiency. She was vaccinated x2 with Pfizer vaccine, admitted on 10/21/21ýwith severe sepsis with mild acute hypoxic respiratory failure from COVID-19 PNA.  ý ý Plan: 1)Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia. Symptom onset on 10/18/21COVID positive on 10/19/21.  - Patient required oxygen via nasal cannula and received Decadron 6 mg daily during hospitalization and Remdesivir 200mg IV x1, followed by 100mg IV daily until clinical improvement (last day on 10/26/21). Patient received course of PO Levofloxacin which was started on 10/22/21 for possible superimposed pneumonia. I discussed with inpatient pharmacist on 10/27/21 and plan for last dose on Thurs 10/28/21.; patient will need follow up CXR in 6 weeks Patient received DVT prophylaxis with Heparin 5,000 units SQ q12h during hospitalization.  I discussed patient with doctor of Pulmonary on 10/28/21 who recommended Prednisone taper on discharge (30 mg PO daily for 3 days, then 20 mg PO daily for 3 days, then 10 mg PO daily for 3 days, then stop). Patient was hypoxic with 02 sat decreased to 87% RA during ambulation on 10/29/21. ý It has been arranged for home 02 with instructions to use 2 liters with activity. ýPatient will have follow-up with Home Health and econsult sent for follow-up oxygen clinic. placed referral for COVID Transitions team follow-up. Isolation through 11/7/21. ý ý2) s/p AKI (Cr increased to 1.51 on 10/21/21); on Lisinopril as outpatient which was held during hospitalization. Cr improved to 0.97 on 10/30/21. It has been arranged for Home Health to draw follow-up chem 7 in 2-3 days. ý 3) HTN; On Lisinopril as outpatient which was held during hospitalization in setting of AKI. Patient continued on Amlodipine 2.5 mg PO daily.  BP's have been stable on Amlodipine and patient was instructed to hold Lisinopril on discharge and PCC has arranged for HHRN for BP check and patient to follow-up with doctor to discuss with patient if Lisinopril should be resumed ý 4) H/o COPD; stable. Continue Stiolto and Rx for Albuterol MDI PRN shortness of breath/wheezing ý ý 5)H/o prediabetes; stable. ýPrior HbAIC 6.0% from 5/20/21. ýPatient not on medications as outpatient.  ý 6) History of gout; stable. ýOn Allupurinol ý Primary Procedures:  None ý Secondary Procedures: 10/21/21 XR Chest ý ý Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood lactic acid normal, Blood potassium decreased, Blood sodium decreased, Blood urea increased
Clinical narrative: Date of Admission: 10/21/2021 ý Date of Discharge: 10/30/2021  69 yo female h/o of past smoking, moderqte COPD/emphysema, HTN, gout, pre-DM, vit D deficiency. She was vaccinated x2 with Pfizer vaccine, admitted on 10/21/21ýwith severe sepsis with mild acute hypoxic respiratory failure from COVID-19 PNA.  ý ý Plan: 1)Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia. Symptom onset on 10/18/21COVID positive on 10/19/21.  - Patient required oxygen via nasal cannula and received Decadron 6 mg daily during hospitalization and Remdesivir 200mg IV x1, followed by 100mg IV daily until clinical improvement (last day on 10/26/21). Patient received course of PO Levofloxacin which was started on 10/22/21 for possible superimposed pneumonia. I discussed with inpatient pharmacist on 10/27/21 and plan for last dose on Thurs 10/28/21.; patient will need follow up CXR in 6 weeks Patient received DVT prophylaxis with Heparin 5,000 units SQ q12h during hospitalization.  I discussed patient with doctor of Pulmonary on 10/28/21 who recommended Prednisone taper on discharge (30 mg PO daily for 3 days, then 20 mg PO daily for 3 days, then 10 mg PO daily for 3 days, then stop). Patient was hypoxic with 02 sat decreased to 87% RA during ambulation on 10/29/21. ý It has been arranged for home 02 with instructions to use 2 liters with activity. ýPatient will have follow-up with Home Health and econsult sent for follow-up oxygen clinic. placed referral for COVID Transitions team follow-up. Isolation through 11/7/21. ý ý2) s/p AKI (Cr increased to 1.51 on 10/21/21); on Lisinopril as outpatient which was held during hospitalization. Cr improved to 0.97 on 10/30/21. It has been arranged for Home Health to draw follow-up chem 7 in 2-3 days. ý 3) HTN; On Lisinopril as outpatient which was held during hospitalization in setting of AKI. Patient continued on Amlodipine 2.5 mg PO daily.  BP's have been stable on Amlodipine and patient was instructed to hold Lisinopril on discharge and PCC has arranged for HHRN for BP check and patient to follow-up with doctor to discuss with patient if Lisinopril should be resumed ý 4) H/o COPD; stable. Continue Stiolto and Rx for Albuterol MDI PRN shortness of breath/wheezing ý ý 5)H/o prediabetes; stable. ýPrior HbAIC 6.0% from 5/20/21. ýPatient not on medications as outpatient.  ý 6) History of gout; stable. ýOn Allupurinol ý Primary Procedures:  None ý Secondary Procedures: 10/21/21 XR Chest ý ý Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide normal, C-reactive protein normal, COVID-19, COVID-19 pneumonia, Carbon dioxide decreased
Clinical narrative: Date of Admission: 10/21/2021 ý Date of Discharge: 10/30/2021  69 yo female h/o of past smoking, moderqte COPD/emphysema, HTN, gout, pre-DM, vit D deficiency. She was vaccinated x2 with Pfizer vaccine, admitted on 10/21/21ýwith severe sepsis with mild acute hypoxic respiratory failure from COVID-19 PNA.  ý ý Plan: 1)Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia. Symptom onset on 10/18/21COVID positive on 10/19/21.  - Patient required oxygen via nasal cannula and received Decadron 6 mg daily during hospitalization and Remdesivir 200mg IV x1, followed by 100mg IV daily until clinical improvement (last day on 10/26/21). Patient received course of PO Levofloxacin which was started on 10/22/21 for possible superimposed pneumonia. I discussed with inpatient pharmacist on 10/27/21 and plan for last dose on Thurs 10/28/21.; patient will need follow up CXR in 6 weeks Patient received DVT prophylaxis with Heparin 5,000 units SQ q12h during hospitalization.  I discussed patient with doctor of Pulmonary on 10/28/21 who recommended Prednisone taper on discharge (30 mg PO daily for 3 days, then 20 mg PO daily for 3 days, then 10 mg PO daily for 3 days, then stop). Patient was hypoxic with 02 sat decreased to 87% RA during ambulation on 10/29/21. ý It has been arranged for home 02 with instructions to use 2 liters with activity. ýPatient will have follow-up with Home Health and econsult sent for follow-up oxygen clinic. placed referral for COVID Transitions team follow-up. Isolation through 11/7/21. ý ý2) s/p AKI (Cr increased to 1.51 on 10/21/21); on Lisinopril as outpatient which was held during hospitalization. Cr improved to 0.97 on 10/30/21. It has been arranged for Home Health to draw follow-up chem 7 in 2-3 days. ý 3) HTN; On Lisinopril as outpatient which was held during hospitalization in setting of AKI. Patient continued on Amlodipine 2.5 mg PO daily.  BP's have been stable on Amlodipine and patient was instructed to hold Lisinopril on discharge and PCC has arranged for HHRN for BP check and patient to follow-up with doctor to discuss with patient if Lisinopril should be resumed ý 4) H/o COPD; stable. Continue Stiolto and Rx for Albuterol MDI PRN shortness of breath/wheezing ý ý 5)H/o prediabetes; stable. ýPrior HbAIC 6.0% from 5/20/21. ýPatient not on medications as outpatient.  ý 6) History of gout; stable. ýOn Allupurinol ý Primary Procedures:  None ý Secondary Procedures: 10/21/21 XR Chest ý ý Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Glomerular filtration rate decreased, Haematocrit normal, Haemoglobin normal, International normalised ratio normal
Clinical narrative: Date of Admission: 10/21/2021 ý Date of Discharge: 10/30/2021  69 yo female h/o of past smoking, moderqte COPD/emphysema, HTN, gout, pre-DM, vit D deficiency. She was vaccinated x2 with Pfizer vaccine, admitted on 10/21/21ýwith severe sepsis with mild acute hypoxic respiratory failure from COVID-19 PNA.  ý ý Plan: 1)Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia. Symptom onset on 10/18/21COVID positive on 10/19/21.  - Patient required oxygen via nasal cannula and received Decadron 6 mg daily during hospitalization and Remdesivir 200mg IV x1, followed by 100mg IV daily until clinical improvement (last day on 10/26/21). Patient received course of PO Levofloxacin which was started on 10/22/21 for possible superimposed pneumonia. I discussed with inpatient pharmacist on 10/27/21 and plan for last dose on Thurs 10/28/21.; patient will need follow up CXR in 6 weeks Patient received DVT prophylaxis with Heparin 5,000 units SQ q12h during hospitalization.  I discussed patient with doctor of Pulmonary on 10/28/21 who recommended Prednisone taper on discharge (30 mg PO daily for 3 days, then 20 mg PO daily for 3 days, then 10 mg PO daily for 3 days, then stop). Patient was hypoxic with 02 sat decreased to 87% RA during ambulation on 10/29/21. ý It has been arranged for home 02 with instructions to use 2 liters with activity. ýPatient will have follow-up with Home Health and econsult sent for follow-up oxygen clinic. placed referral for COVID Transitions team follow-up. Isolation through 11/7/21. ý ý2) s/p AKI (Cr increased to 1.51 on 10/21/21); on Lisinopril as outpatient which was held during hospitalization. Cr improved to 0.97 on 10/30/21. It has been arranged for Home Health to draw follow-up chem 7 in 2-3 days. ý 3) HTN; On Lisinopril as outpatient which was held during hospitalization in setting of AKI. Patient continued on Amlodipine 2.5 mg PO daily.  BP's have been stable on Amlodipine and patient was instructed to hold Lisinopril on discharge and PCC has arranged for HHRN for BP check and patient to follow-up with doctor to discuss with patient if Lisinopril should be resumed ý 4) H/o COPD; stable. Continue Stiolto and Rx for Albuterol MDI PRN shortness of breath/wheezing ý ý 5)H/o prediabetes; stable. ýPrior HbAIC 6.0% from 5/20/21. ýPatient not on medications as outpatient.  ý 6) History of gout; stable. ýOn Allupurinol ý Primary Procedures:  None ý Secondary Procedures: 10/21/21 XR Chest ý ý Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test normal, Lipase normal, Lymphocyte percentage decreased, Mean cell volume normal, Monocyte percentage
Clinical narrative: Date of Admission: 10/21/2021 ý Date of Discharge: 10/30/2021  69 yo female h/o of past smoking, moderqte COPD/emphysema, HTN, gout, pre-DM, vit D deficiency. She was vaccinated x2 with Pfizer vaccine, admitted on 10/21/21ýwith severe sepsis with mild acute hypoxic respiratory failure from COVID-19 PNA.  ý ý Plan: 1)Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia. Symptom onset on 10/18/21COVID positive on 10/19/21.  - Patient required oxygen via nasal cannula and received Decadron 6 mg daily during hospitalization and Remdesivir 200mg IV x1, followed by 100mg IV daily until clinical improvement (last day on 10/26/21). Patient received course of PO Levofloxacin which was started on 10/22/21 for possible superimposed pneumonia. I discussed with inpatient pharmacist on 10/27/21 and plan for last dose on Thurs 10/28/21.; patient will need follow up CXR in 6 weeks Patient received DVT prophylaxis with Heparin 5,000 units SQ q12h during hospitalization.  I discussed patient with doctor of Pulmonary on 10/28/21 who recommended Prednisone taper on discharge (30 mg PO daily for 3 days, then 20 mg PO daily for 3 days, then 10 mg PO daily for 3 days, then stop). Patient was hypoxic with 02 sat decreased to 87% RA during ambulation on 10/29/21. ý It has been arranged for home 02 with instructions to use 2 liters with activity. ýPatient will have follow-up with Home Health and econsult sent for follow-up oxygen clinic. placed referral for COVID Transitions team follow-up. Isolation through 11/7/21. ý ý2) s/p AKI (Cr increased to 1.51 on 10/21/21); on Lisinopril as outpatient which was held during hospitalization. Cr improved to 0.97 on 10/30/21. It has been arranged for Home Health to draw follow-up chem 7 in 2-3 days. ý 3) HTN; On Lisinopril as outpatient which was held during hospitalization in setting of AKI. Patient continued on Amlodipine 2.5 mg PO daily.  BP's have been stable on Amlodipine and patient was instructed to hold Lisinopril on discharge and PCC has arranged for HHRN for BP check and patient to follow-up with doctor to discuss with patient if Lisinopril should be resumed ý 4) H/o COPD; stable. Continue Stiolto and Rx for Albuterol MDI PRN shortness of breath/wheezing ý ý 5)H/o prediabetes; stable. ýPrior HbAIC 6.0% from 5/20/21. ýPatient not on medications as outpatient.  ý 6) History of gout; stable. ýOn Allupurinol ý Primary Procedures:  None ý Secondary Procedures: 10/21/21 XR Chest ý ý Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Neutrophil percentage increased, Oxygen saturation decreased, Platelet count normal, Prothrombin time prolonged, Red blood cell count normal
Clinical narrative: Date of Admission: 10/21/2021 ý Date of Discharge: 10/30/2021  69 yo female h/o of past smoking, moderqte COPD/emphysema, HTN, gout, pre-DM, vit D deficiency. She was vaccinated x2 with Pfizer vaccine, admitted on 10/21/21ýwith severe sepsis with mild acute hypoxic respiratory failure from COVID-19 PNA.  ý ý Plan: 1)Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia. Symptom onset on 10/18/21COVID positive on 10/19/21.  - Patient required oxygen via nasal cannula and received Decadron 6 mg daily during hospitalization and Remdesivir 200mg IV x1, followed by 100mg IV daily until clinical improvement (last day on 10/26/21). Patient received course of PO Levofloxacin which was started on 10/22/21 for possible superimposed pneumonia. I discussed with inpatient pharmacist on 10/27/21 and plan for last dose on Thurs 10/28/21.; patient will need follow up CXR in 6 weeks Patient received DVT prophylaxis with Heparin 5,000 units SQ q12h during hospitalization.  I discussed patient with doctor of Pulmonary on 10/28/21 who recommended Prednisone taper on discharge (30 mg PO daily for 3 days, then 20 mg PO daily for 3 days, then 10 mg PO daily for 3 days, then stop). Patient was hypoxic with 02 sat decreased to 87% RA during ambulation on 10/29/21. ý It has been arranged for home 02 with instructions to use 2 liters with activity. ýPatient will have follow-up with Home Health and econsult sent for follow-up oxygen clinic. placed referral for COVID Transitions team follow-up. Isolation through 11/7/21. ý ý2) s/p AKI (Cr increased to 1.51 on 10/21/21); on Lisinopril as outpatient which was held during hospitalization. Cr improved to 0.97 on 10/30/21. It has been arranged for Home Health to draw follow-up chem 7 in 2-3 days. ý 3) HTN; On Lisinopril as outpatient which was held during hospitalization in setting of AKI. Patient continued on Amlodipine 2.5 mg PO daily.  BP's have been stable on Amlodipine and patient was instructed to hold Lisinopril on discharge and PCC has arranged for HHRN for BP check and patient to follow-up with doctor to discuss with patient if Lisinopril should be resumed ý 4) H/o COPD; stable. Continue Stiolto and Rx for Albuterol MDI PRN shortness of breath/wheezing ý ý 5)H/o prediabetes; stable. ýPrior HbAIC 6.0% from 5/20/21. ýPatient not on medications as outpatient.  ý 6) History of gout; stable. ýOn Allupurinol ý Primary Procedures:  None ý Secondary Procedures: 10/21/21 XR Chest ý ý Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Troponin I normal, White blood cell count decreased
Clinical narrative: Date of Admission: 10/21/2021 ý Date of Discharge: 10/30/2021  69 yo female h/o of past smoking, moderqte COPD/emphysema, HTN, gout, pre-DM, vit D deficiency. She was vaccinated x2 with Pfizer vaccine, admitted on 10/21/21ýwith severe sepsis with mild acute hypoxic respiratory failure from COVID-19 PNA.  ý ý Plan: 1)Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia. Symptom onset on 10/18/21COVID positive on 10/19/21.  - Patient required oxygen via nasal cannula and received Decadron 6 mg daily during hospitalization and Remdesivir 200mg IV x1, followed by 100mg IV daily until clinical improvement (last day on 10/26/21). Patient received course of PO Levofloxacin which was started on 10/22/21 for possible superimposed pneumonia. I discussed with inpatient pharmacist on 10/27/21 and plan for last dose on Thurs 10/28/21.; patient will need follow up CXR in 6 weeks Patient received DVT prophylaxis with Heparin 5,000 units SQ q12h during hospitalization.  I discussed patient with doctor of Pulmonary on 10/28/21 who recommended Prednisone taper on discharge (30 mg PO daily for 3 days, then 20 mg PO daily for 3 days, then 10 mg PO daily for 3 days, then stop). Patient was hypoxic with 02 sat decreased to 87% RA during ambulation on 10/29/21. ý It has been arranged for home 02 with instructions to use 2 liters with activity. ýPatient will have follow-up with Home Health and econsult sent for follow-up oxygen clinic. placed referral for COVID Transitions team follow-up. Isolation through 11/7/21. ý ý2) s/p AKI (Cr increased to 1.51 on 10/21/21); on Lisinopril as outpatient which was held during hospitalization. Cr improved to 0.97 on 10/30/21. It has been arranged for Home Health to draw follow-up chem 7 in 2-3 days. ý 3) HTN; On Lisinopril as outpatient which was held during hospitalization in setting of AKI. Patient continued on Amlodipine 2.5 mg PO daily.  BP's have been stable on Amlodipine and patient was instructed to hold Lisinopril on discharge and PCC has arranged for HHRN for BP check and patient to follow-up with doctor to discuss with patient if Lisinopril should be resumed ý 4) H/o COPD; stable. Continue Stiolto and Rx for Albuterol MDI PRN shortness of breath/wheezing ý ý 5)H/o prediabetes; stable. ýPrior HbAIC 6.0% from 5/20/21. ýPatient not on medications as outpatient.  ý 6) History of gout; stable. ýOn Allupurinol ý Primary Procedures:  None ý Secondary Procedures: 10/21/21 XR Chest ý ý Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No Adverse event. On 11/03/2021 the Vaccine Refrig data logger showed a temperature excursion occurred on 10/29/2021 at 10:48 a.m. of +50.7 (F). The timeframe documented is 13 mins with n 5 min alarm notification totaling 18 min. The vaccine providers were not aware that the vaccine needed to be used within a 24 hour timeframe of the excursion prior to discussion on 11/3/2021. A clinic was scheduled for Moderna Booster doses at a High School for their employees for 11/1/2021. This clinic did occur with the Moderna Vaccine with Lot # 076C21A between the hours of 3:00-5:00 p.m. A total of 16 people received Moderna Booster shots 0.25ml.The vaccine provider learned on 11/3/2021 in conversations with the health department that due to the excursion, the vaccine should be discarded if not used within 24 hours of the temperature excursion. With the instructional education provided, all remaining doses of Moderna with Lot# 076C21A was wasted.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: I have been having numbness my tongue, lips, both side of fingers and both side of toes. The symptoms level is same since o noticed them. Mean not getting worse or better.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Aortic valve incompetence, Blood creatine phosphokinase increased, C-reactive protein increased, Chest pain, Dyspnoea
Clinical narrative: Myocarditis chest pain, SOB with elevated troponin and CK, ESR and CRP. No signs of ischemia on echocardiogram
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Ejection fraction, Left ventricular hypertrophy, Mitral valve incompetence, Mitral valve stenosis
Clinical narrative: Myocarditis chest pain, SOB with elevated troponin and CK, ESR and CRP. No signs of ischemia on echocardiogram
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Myocarditis, Red blood cell sedimentation rate increased, Troponin increased
Clinical narrative: Myocarditis chest pain, SOB with elevated troponin and CK, ESR and CRP. No signs of ischemia on echocardiogram
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Cardiac flutter, Cardiac monitoring, Chest X-ray, Electrocardiogram
Clinical narrative: My heart starting skipping beats and fluttering, month (October) long cold, and stomach flu (September)
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Extrasystoles, Gastroenteritis viral, Nasopharyngitis
Clinical narrative: My heart starting skipping beats and fluttering, month (October) long cold, and stomach flu (September)
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Headache and dizziness.  Treatment for ongoing dizziness is meclizine prescribed by PCP.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Product storage error
Clinical narrative: No Adverse event. On 11/03/2021 the Vaccine Refrig data logger showed a temperature excursion occurred on 10/29/2021 at 10:48 a.m. of +50.7 (F). The timeframe documented is 13 mins with n 5 min alarm notification totaling 18 min. The vaccine providers were not aware that the vaccine needed to be used within a 24 hour timeframe of the excursion prior to discussion with the health department on 11/3/2021. A clinic was scheduled for Moderna Booster doses at a High School for their employees for 11/1/2021. This clinic did occur with the Moderna Vaccine with Lot # 076C21A between the hours of 3:00-5:00 p.m. A total of 16 people received Moderna Booster shots 0.25ml.  The vaccine provider learned on 11/3/2021 in conversations with the health department that due to the excursion, the vaccine should be discarded if not used within 24 hours of the temperature excursion. With the instructional education provided via the health department, all remaining doses of Moderna with Lot# 076C21A was wasted.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Interchange of vaccine products
Clinical narrative: Not so much an "adverse event" however, pt came into the office on 11/05/2021 to see provider for a routine follow-up appointment and his second dose of Pfizer. Upon speaking with the provider, he did confess that he has received 5 doses of Moderna (3/21, 4/21, 7/21, 8/21, and 9/21). Unfortunately, he was not honest during his 10/14/21 appt and did receive a dose of Pfizer from our facility as he stated he had not been vaccinated against covid-19.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Nurse on duty at our clinic was discovered to have given a dose of Pfizer to this patient when vial was punctured and reconstituted 3 days prior.  Nurse states she first punctured vial on 10/26/2021 and reconstituted to administer a few doses on that day.  She then proceeded to return the Pfizer vaccine vial to the fridge at 2-8 degrees C and re-punctured vial on 10/29/2021 to administer to this patient. Patient remained in clinic x 20 minutes and no s/s reaction reported up to this date.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Dizziness, Erythema
Clinical narrative: About 2 hours after receiving the vaccine, my arm became very sore and red.  I started feeling dizzy and light headed so I went to bed. I woke up around 1am and I could not move my arm. It was hot to the touch, red swollen and itchy. I had fever of 101 and could barely walk to the bathroom. For the next week I experienced, nausea, vomiting, diarrhea, fatigue, dizziness, fevers ranging from 99-101.9, chills, muscle and joint pain. body aches. I could barely move my arm or even get around my house. I could not work. I eventually called my doctor and made an appt, she said that there was not much she could do besides test me for flu and covid, and give me nausea medicine. As her and I both knew I was going to react to the vaccine but I did not have a choice in getting in it. She was not allowed to write me an exemption either.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Gait disturbance, Impaired work ability, Influenza virus test negative
Clinical narrative: About 2 hours after receiving the vaccine, my arm became very sore and red.  I started feeling dizzy and light headed so I went to bed. I woke up around 1am and I could not move my arm. It was hot to the touch, red swollen and itchy. I had fever of 101 and could barely walk to the bathroom. For the next week I experienced, nausea, vomiting, diarrhea, fatigue, dizziness, fevers ranging from 99-101.9, chills, muscle and joint pain. body aches. I could barely move my arm or even get around my house. I could not work. I eventually called my doctor and made an appt, she said that there was not much she could do besides test me for flu and covid, and give me nausea medicine. As her and I both knew I was going to react to the vaccine but I did not have a choice in getting in it. She was not allowed to write me an exemption either.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia, Nausea, Pain, Pain in extremity
Clinical narrative: About 2 hours after receiving the vaccine, my arm became very sore and red.  I started feeling dizzy and light headed so I went to bed. I woke up around 1am and I could not move my arm. It was hot to the touch, red swollen and itchy. I had fever of 101 and could barely walk to the bathroom. For the next week I experienced, nausea, vomiting, diarrhea, fatigue, dizziness, fevers ranging from 99-101.9, chills, muscle and joint pain. body aches. I could barely move my arm or even get around my house. I could not work. I eventually called my doctor and made an appt, she said that there was not much she could do besides test me for flu and covid, and give me nausea medicine. As her and I both knew I was going to react to the vaccine but I did not have a choice in getting in it. She was not allowed to write me an exemption either.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Pyrexia, SARS-CoV-2 test negative, Vomiting
Clinical narrative: About 2 hours after receiving the vaccine, my arm became very sore and red.  I started feeling dizzy and light headed so I went to bed. I woke up around 1am and I could not move my arm. It was hot to the touch, red swollen and itchy. I had fever of 101 and could barely walk to the bathroom. For the next week I experienced, nausea, vomiting, diarrhea, fatigue, dizziness, fevers ranging from 99-101.9, chills, muscle and joint pain. body aches. I could barely move my arm or even get around my house. I could not work. I eventually called my doctor and made an appt, she said that there was not much she could do besides test me for flu and covid, and give me nausea medicine. As her and I both knew I was going to react to the vaccine but I did not have a choice in getting in it. She was not allowed to write me an exemption either.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: 3 Days after the 2nd Covid shot my daughter started her period despite the fact that she is on birth control daily to help with bad menstrual cramps and migraines that seem hormone triggered and she hasn't had a period for a few months. After the 2nd shot her period came back within days and lasted for two weeks which has never happened in her entire life and is not normal in my experience for any woman. It was heavier than normal bleeding for longer than she has ever experienced. Then again the next month she got a very painful period again despite taking her Norlyda pill as prescribed daily. It really seems like all of this was connected to her receiving the second vaccine. A friend of mine warned us of this as it happened to her too and her periods had been regular her whole life so it really stood out to her too as abnormal. Our greatest concern is for our daughter's future fertility.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza virus test, Pain, Pneumonia, SARS-CoV-2 test
Clinical narrative: Pneumonia and soreness ache.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram normal, Pelvic pain, Ultrasound scan normal, Vaginal haemorrhage
Clinical narrative: severe pelvic pain with heavy bleeding
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: No Adverse event. On 11/03/2021 the Vaccine Refrig data logger showed a temperature excursion occurred on 10/29/2021 at 10:48 a.m. of +50.7 (F). The timeframe documented is 13 mins with n 5 min alarm notification totaling 18 min. The vaccine providers were not aware that the vaccine needed to be used within a 24 hour timeframe of the excursion prior to discussion with an authority on 11/3/2021. A clinic was scheduled for Moderna Booster doses at a High School for their employees for 11/1/2021. This clinic did occur with the Moderna Vaccine with Lot # 076C21A between the hours of 3:00-5:00 p.m. A total of 16 people received Moderna Booster shots 0.25ml.  The vaccine provider learned on 11/3/2021 in conversations with the health department that due to the excursion, the vaccine should be discarded if not used within 24 hours of the temperature excursion. With the instructional education provided via the health department, all remaining doses of Moderna with Lot# 076C21A was wasted.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram cerebral abnormal, Cerebral haemorrhage, Computerised tomogram head abnormal, Head discomfort, Headache
Clinical narrative: On July 17th, around 6PM, I felt a sudden, abrupt stiffness in the bottom of my neck to the top of my neck.  My neck became incredibly tense.  I started vomiting.   Throughout the night I felt a lot of head pressure that I'd never felt before.   When I woke up around 9AM, on July 18th, I had an extremely excruciating headache.  At that point, we decided to go the ER at the Hospital.  We got to the hospital around Noon.   They did the initial CT scan and found a brain bleed.  Around 3PM, they transferred me, via ambulance, to another hospital, which has better capacity to perform neurological procedures. I was at that Hospital from July 18th to 28th in the ICU.  Diagnosis was Subarachnoid Hemorrhage